Metastatic Breast Cancer
Also known as:Metastatic (Stage IV) Breast Cancer/Advanced/Metastatic Breast Cancer/Stage IV (Metastatic) Breast Cancer/Metastatic Breast Cancers/Breast cancer metastatic/Carcinoma breast stage IV/Breast carcinoma NOS stage IV/Breast carcinoma stage IV/Breast cancer stage IV/Breast cancer NOS stage IV
Drug | Drug Name | Drug Description |
---|---|---|
DB01217 | Anastrozole | A competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of hormone receptor-positive breast cancer in postmenopausal women. |
DB01101 | Capecitabine | 一种核苷代谢抑制剂indicated to treat colon, colorectal and breast cancer. |
DB00958 | Carboplatin | A alkylating agent used to treat advanced ovarian cancer. |
DB00286 | Conjugated estrogens | 美国东部时间的混合物rogens used in estrogen replacement therapy for menopause and hypoestrogenism, used in the treatment of various malignancies, and used in the treatment of postmenopausal osteoporosis. |
DB00380 | Dexrazoxane | A cytoprotective drug used to prevent and improve cardiomyopathy associated with doxorubicin treatment for metastatic breast cancer. |
DB01248 | Docetaxel | A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. |
DB00997 | Doxorubicin | A medication used to treat various cancers and Kaposi's Sarcoma. |
DB09381 | Esterified estrogens | A female hormone used to treat conditions related to estrogen deficiency and moderate to severe vasomotor menopausal symptoms in women. |
DB00783 | Estradiol | An estrogenic steroid used to treat vasomotor symptoms of vulvar and vaginal atrophy in menopause, hypoestrogenism, prevention of postmenopausal osteoporosis, treatment of breast cancer, and advanced androgen-dependent carcinoma of the prostate. |
DB00441 | Gemcitabine | 一种核苷代谢抑制剂used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. |
DB06205 | Hyaluronidase (human recombinant) | An enzyme used to improve the absorption and dispersion of parenterally administered fluids, drugs, and contrast agents. |
DB04845 | Ixabepilone | 一种微管抑制剂联合管理n with capecitabine or alone in the treatment of metastatic or locally advanced breast cancer that has shown inadequate response to taxanes and anthracyclines. |
DB01259 | Lapatinib | An antineoplastic agent and tyrosine kinase inhibitor used for the treatment of advanced or metastatic HER-negative breast cancer in patients who received prior chemotherapeutic treatments. |
DB06710 | Methyltestosterone | A synthetic anabolic steroid used for the replacement therapy in conditions associated with testosterone deficiencies in males, such as hypogonadism, and treatment of advancing inoperable metastatic breast cancer in females. |
DB01204 | Mitoxantrone | A chemotherapeutic agent used for the treatment of secondary progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis. |
DB09074 | Olaparib | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. |
DB01229 | Paclitaxel | A taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer. |
DB09073 | Palbociclib | An endocrine-based chemotherapeutic agent used in combination with other antineoplastic agents to treat HER2-negative and HR-positive advanced or metastatic breast cancer. |
DB06366 | Pertuzumab | An antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents. |
DB11730 | Ribociclib | A kinase inhibitor used to treat HR+, HER2- advanced or metastatic breast cancer. |
DB11760 | Talazoparib | A poly-ADP ribose polymerase inhibitor used to treat HER2-, BRCA mutated locally advanced or metastatic breast cancer. |
DB00539 | Toremifene | A first generation nonsteroidal selective estrogen receptor modulator used to treat certain breast cancers. |
DB00072 | Trastuzumab | A monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. |
DB00361 | Vinorelbine | A vinca alkaloid used in the treatment of metastatic non-small cell lung carcinoma (NSLC) and in conjunction with other drugs in locally advanced NSCLC. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00112 | Bevacizumab | 0 | Completed | 1 |
DB16429 | CoVac-1 | 0 | Completed | 1 |
DB11714 | Durvalumab | 0 | Completed | 1 |
DB00947 | Fulvestrant | 0 | Active Not Recruiting | 1 |
DB05382 | Iodine | 0 | Terminated | 1 |
DB09073 | Palbociclib | 0 | Active Not Recruiting | 1 |
DB00675 | Tamoxifen | 0 | Active Not Recruiting | 1 |
DB12001 | Abemaciclib | 1 | Completed | 1 |
DB12001 | Abemaciclib | 1 | Recruiting | 1 |
DB08885 | Aflibercept | 1 | Completed | 1 |
DB00062 | Albumin human | 1 | Completed | 1 |
DB05220 | Alisertib | 1 | Completed | 1 |
DB12015 | Alpelisib | 1 | Completed | 1 |
DB12015 | Alpelisib | 1 | Not Yet Recruiting | 1 |
DB12015 | Alpelisib | 1 | Recruiting | 2 |
DB00026 | Anakinra | 1 | Completed | 1 |
DB01217 | Anastrozole | 1 | Recruiting | 1 |
DB06692 | Aprotinin | 1 | Terminated | 1 |
DB09274 | Artesunate | 1 | Completed | 1 |
DB11945 | Avelumab | 1 | Recruiting | 1 |
DB00928 | Azacitidine | 1 | Completed | 1 |
DB05015 | Belinostat | 1 | Recruiting | 2 |
DB06769 | Bendamustine | 1 | Completed | 1 |
DB11105 | Benzalkonium | 1 | Completed | 1 |
DB11105 | Benzalkonium | 1 | Not Yet Recruiting | 1 |
DB15387 | Bintrafusp alfa | 1 | Terminated | 1 |
DB06616 | Bosutinib | 1 | Recruiting | 1 |
DB11666 | Buparlisib | 1 | Completed | 2 |
DB01101 | Capecitabine | 1 | Active Not Recruiting | 1 |
DB01101 | Capecitabine | 1 | Completed | 11 |
DB01101 | Capecitabine | 1 | Recruiting | 2 |
DB01101 | Capecitabine | 1 | Terminated | 1 |
DB12218 | Capivasertib | 1 | Recruiting | 1 |
DB00002 | Cetuximab | 1 | Unknown Status | 1 |
DB00515 | Cisplatin | 1 | Completed | 1 |
DB12483 | Copanlisib | 1 | Terminated | 1 |
DB16380 | Coprelotamab | 1 | Completed | 1 |
DB00531 | Cyclophosphamide | 1 | Completed | 1 |
DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
DB00091 | Cyclosporine | 1 | Completed | 1 |
DB11651 | Dactolisib | 1 | Completed | 3 |
DB01248 | Docetaxel | 1 | Active Not Recruiting | 1 |
DB01248 | Docetaxel | 1 | Completed | 4 |
DB01248 | Docetaxel | 1 | Terminated | 1 |
DB00997 | Doxorubicin | 1 | Recruiting | 1 |
DB11714 | Durvalumab | 1 | Completed | 1 |
DB11714 | Durvalumab | 1 | Recruiting | 1 |
DB16150 | Eftilagimod alfa | 1 | Completed | 1 |
DB16150 | Eftilagimod alfa | 1 | Not Yet Recruiting | 1 |
DB06374 | Elacestrant | 1 | Completed | 1 |
DB11841 | Entinostat | 1 | Recruiting | 1 |
DB11841 | Entinostat | 1 | Terminated | 1 |
DB00445 | Epirubicin | 1 | Completed | 2 |
DB12147 | Erdafitinib | 1 | Active Not Recruiting | 1 |
DB08871 | Eribulin | 1 | Completed | 1 |
DB01590 | Everolimus | 1 | Completed | 2 |
DB01590 | Everolimus | 1 | Recruiting | 1 |
DB00990 | Exemestane | 1 | Withdrawn | 1 |
DB13034 | Foxy-5 | 1 | Completed | 2 |
DB11679 | Fruquintinib | 1 | Recruiting | 1 |
DB00947 | Fulvestrant | 1 | Active Not Recruiting | 1 |
DB00947 | Fulvestrant | 1 | Completed | 1 |
DB00947 | Fulvestrant | 1 | Recruiting | 5 |
DB11896 | Gedatolisib | 1 | Completed | 1 |
DB00441 | Gemcitabine | 1 | Completed | 2 |
DB00014 | Goserelin | 1 | Withdrawn | 1 |
DB12672 | Icaritin | 1 | Unknown Status | 1 |
DB00724 | Imiquimod | 1 | Terminated | 1 |
DB11743 | Ipatasertib | 1 | Recruiting | 1 |
DB04845 | Ixabepilone | 1 | Completed | 1 |
DB12167 | LY-3023414 | 1 | Completed | 1 |
DB01259 | Lapatinib | 1 | Completed | 5 |
DB01259 | Lapatinib | 1 | Terminated | 1 |
DB01006 | Letrozole | 1 | Completed | 2 |
DB01006 | Letrozole | 1 | Recruiting | 1 |
DB12674 | Lurbinectedin | 1 | Completed | 1 |
DB15306 | MEDI-6469 | 1 | Completed | 1 |
DB00563 | Methotrexate | 1 | Completed | 1 |
DB00683 | Midazolam | 1 | Completed | 2 |
DB12005 | Nirogacestat | 1 | Terminated | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 1 | Completed | 1 |
DB09074 | Olaparib | 1 | Recruiting | 2 |
DB12637 | Onapristone | 1 | Recruiting | 1 |
DB05173 | PTC299 | 1 | Completed | 1 |
DB12638 | PU-H71 | 1 | Completed | 1 |
DB01229 | Paclitaxel | 1 | Active Not Recruiting | 2 |
DB01229 | Paclitaxel | 1 | Completed | 12 |
DB01229 | Paclitaxel | 1 | Not Yet Recruiting | 1 |
DB01229 | Paclitaxel | 1 | Recruiting | 2 |
DB13809 | Paclitaxel poliglumex | 1 | Completed | 1 |
DB09073 | Palbociclib | 1 | Active Not Recruiting | 2 |
DB09073 | Palbociclib | 1 | Recruiting | 5 |
DB06603 | Panobinostat | 1 | Completed | 1 |
DB06589 | Pazopanib | 1 | Completed | 1 |
DB06589 | Pazopanib | 1 | Terminated | 1 |
DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Terminated | 1 |
DB00642 | Pemetrexed | 1 | Completed | 1 |
DB06366 | Pertuzumab | 1 | Active Not Recruiting | 1 |
DB06366 | Pertuzumab | 1 | Recruiting | 2 |
DB00780 | Phenelzine | 1 | Completed | 1 |
DB11663 | Pictilisib | 1 | Completed | 1 |
DB12257 | Platinum | 1 | Completed | 1 |
DB16065 | Proxalutamide | 1 | Completed | 1 |
DB14993 | Pyrotinib | 1 | Active Not Recruiting | 1 |
DB14993 | Pyrotinib | 1 | Completed | 1 |
DB16751 | RLY-2608 | 1 | Recruiting | 1 |
DB05578 | Ramucirumab | 1 | Completed | 1 |
DB12614 | Reparixin | 1 | Completed | 1 |
DB11730 | Ribociclib | 1 | Active Not Recruiting | 1 |
DB11730 | Ribociclib | 1 | Not Yet Recruiting | 1 |
DB11730 | Ribociclib | 1 | Recruiting | 1 |
DB12376 | Ricolinostat | 1 | Completed | 1 |
DB15078 | Rogaratinib | 1 | Recruiting | 1 |
DB11182 | Rose bengal | 1 | Recruiting | 1 |
DB11836 | Sapanisertib | 1 | Completed | 1 |
DB09143 | Sonidegib | 1 | Completed | 1 |
DB00398 | Sorafenib | 1 | Completed | 1 |
DB06271 | Sulodexide | 1 | Completed | 1 |
DB11760 | Talazoparib | 1 | Recruiting | 2 |
DB12108 | Taselisib | 1 | Active Not Recruiting | 1 |
DB00853 | Temozolomide | 1 | Completed | 1 |
DB11800 | Tivozanib | 1 | Completed | 1 |
DB00072 | Trastuzumab | 1 | Active Not Recruiting | 3 |
DB00072 | Trastuzumab | 1 | Completed | 8 |
DB00072 | Trastuzumab | 1 | Recruiting | 3 |
DB00072 | Trastuzumab | 1 | Unknown Status | 1 |
DB14962 | Trastuzumab deruxtecan | 1 | Recruiting | 1 |
DB16342 | Trastuzumab duocarmazine | 1 | Recruiting | 1 |
DB05773 | Trastuzumab emtansine | 1 | Active Not Recruiting | 2 |
DB05773 | Trastuzumab emtansine | 1 | Completed | 3 |
DB05773 | Trastuzumab emtansine | 1 | Terminated | 2 |
DB11771 | Tremelimumab | 1 | Terminated | 1 |
DB06333 | Trodusquemine | 1 | Terminated | 1 |
DB05294 | Vandetanib | 1 | Completed | 1 |
DB12956 | Vantictumab | 1 | Completed | 1 |
DB00361 | Vinorelbine | 1 | Completed | 2 |
DB00361 | Vinorelbine | 1 | Terminated | 2 |
DB02546 | Vorinostat | 1 | Recruiting | 1 |
DB05531 | alpha-Pyrrolidinononanophenone | 1 | Recruiting | 1 |
DB11881 | AUY922 | 1 / 2 | Withdrawn | 1 |
DB05812 | Abiraterone | 1 / 2 | Recruiting | 1 |
DB05220 | Alisertib | 1 / 2 | Completed | 1 |
DB06263 | Amrubicin | 1 / 2 | Completed | 1 |
DB11595 | Atezolizumab | 1 / 2 | Recruiting | 1 |
DB05051 | BZL101 | 1 / 2 | Completed | 1 |
DB01128 | Bicalutamide | 1 / 2 | Active Not Recruiting | 1 |
DB14846 | Bimiralisib | 1 / 2 | Completed | 1 |
DB11666 | Buparlisib | 1 / 2 | Terminated | 1 |
DB01101 | Capecitabine | 1 / 2 | Completed | 2 |
DB01101 | Capecitabine | 1 / 2 | Terminated | 1 |
DB01101 | Capecitabine | 1 / 2 | Withdrawn | 1 |
DB11791 | Capmatinib | 1 / 2 | Recruiting | 1 |
DB06322 | Carotuximab | 1 / 2 | Completed | 1 |
DB00515 | Cisplatin | 1 / 2 | Terminated | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Completed | 1 |
DB11651 | Dactolisib | 1 / 2 | Terminated | 1 |
DB12941 | Darolutamide | 1 / 2 | Recruiting | 1 |
DB01254 | Dasatinib | 1 / 2 | Completed | 2 |
DB01248 | Docetaxel | 1 / 2 | Completed | 2 |
DB01248 | Docetaxel | 1 / 2 | Terminated | 1 |
DB00997 | Doxorubicin | 1 / 2 | Completed | 1 |
DB00997 | Doxorubicin | 1 / 2 | Terminated | 1 |
DB11714 | Durvalumab | 1 / 2 | Recruiting | 1 |
DB08899 | Enzalutamide | 1 / 2 | Recruiting | 1 |
DB04940 | Eribulin | 1 / 2 | Completed | 1 |
DB08871 | Eribulin | 1 / 2 | Completed | 3 |
DB04940 | Eribulin | 1 / 2 | Terminated | 1 |
DB08871 | Eribulin | 1 / 2 | Terminated | 1 |
DB01590 | Everolimus | 1 / 2 | Terminated | 1 |
DB00990 | Exemestane | 1 / 2 | Terminated | 1 |
DB11741 | Famitinib | 1 / 2 | Recruiting | 1 |
DB00099 | Filgrastim | 1 / 2 | Terminated | 1 |
DB00947 | Fulvestrant | 1 / 2 | Recruiting | 2 |
DB00947 | Fulvestrant | 1 / 2 | Withdrawn | 1 |
DB00441 | Gemcitabine | 1 / 2 | Terminated | 1 |
DB00724 | Imiquimod | 1 / 2 | Completed | 1 |
DB06169 | Indibulin | 1 / 2 | Unknown Status | 1 |
DB04845 | Ixabepilone | 1 / 2 | Completed | 2 |
DB04845 | Ixabepilone | 1 / 2 | Withdrawn | 1 |
DB01259 | Lapatinib | 1 / 2 | Completed | 3 |
DB01259 | Lapatinib | 1 / 2 | Terminated | 1 |
DB01006 | Letrozole | 1 / 2 | Active Not Recruiting | 1 |
DB01006 | Letrozole | 1 / 2 | Recruiting | 1 |
DB01006 | Letrozole | 1 / 2 | Terminated | 1 |
DB12852 | MK-0752 | 1 / 2 | Completed | 1 |
DB05575 | Motesanib | 1 / 2 | Withdrawn | 1 |
DB11828 | Neratinib | 1 / 2 | Recruiting | 1 |
DB11793 | Niraparib | 1 / 2 | Completed | 1 |
DB11793 | Niraparib | 1 / 2 | Recruiting | 1 |
DB09035 | Nivolumab | 1 / 2 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 1 / 2 | Recruiting | 1 |
DB15110 | Onvansertib | 1 / 2 | Not Yet Recruiting | 1 |
DB01229 | Paclitaxel | 1 / 2 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 1 / 2 | Completed | 5 |
DB01229 | Paclitaxel | 1 / 2 | Not Yet Recruiting | 1 |
DB01229 | Paclitaxel | 1 / 2 | Recruiting | 2 |
DB01229 | Paclitaxel | 1 / 2 | Terminated | 3 |
DB09073 | Palbociclib | 1 / 2 | Active Not Recruiting | 2 |
DB09073 | Palbociclib | 1 / 2 | Recruiting | 1 |
DB00019 | Pegfilgrastim | 1 / 2 | Completed | 1 |
DB14912 | Pegvorhyaluronidase alfa | 1 / 2 | Terminated | 1 |
DB09037 | Pembrolizumab | 1 / 2 | Completed | 2 |
DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 5 |
DB06366 | Pertuzumab | 1 / 2 | Completed | 2 |
DB06366 | Pertuzumab | 1 / 2 | Recruiting | 1 |
DB12978 | Pexidartinib | 1 / 2 | Completed | 1 |
DB00811 | Ribavirin | 1 / 2 | Terminated | 1 |
DB11730 | Ribociclib | 1 / 2 | Recruiting | 1 |
DB08877 | Ruxolitinib | 1 / 2 | Completed | 2 |
DB16753 | SB719125 | 1 / 2 | Completed | 1 |
DB12621 | ST-101 | 1 / 2 | Recruiting | 1 |
DB12275 | Seviteronel | 1 / 2 | Completed | 1 |
DB00398 | Sorafenib | 1 / 2 | Completed | 1 |
DB00398 | Sorafenib | 1 / 2 | Terminated | 1 |
DB00398 | Sorafenib | 1 / 2 | Unknown Status | 1 |
DB01268 | Sunitinib | 1 / 2 | Terminated | 1 |
DB09499 | Thiosulfuric acid | 1 / 2 | Recruiting | 1 |
DB00072 | Trastuzumab | 1 / 2 | Active Not Recruiting | 1 |
DB00072 | Trastuzumab | 1 / 2 | Completed | 4 |
DB00072 | Trastuzumab | 1 / 2 | Recruiting | 2 |
DB00072 | Trastuzumab | 1 / 2 | Terminated | 3 |
DB14962 | Trastuzumab deruxtecan | 1 / 2 | Recruiting | 1 |
DB16342 | Trastuzumab duocarmazine | 1 / 2 | Recruiting | 1 |
DB05773 | Trastuzumab emtansine | 1 / 2 | Active Not Recruiting | 1 |
DB05773 | Trastuzumab emtansine | 1 / 2 | Completed | 2 |
DB05773 | Trastuzumab emtansine | 1 / 2 | Terminated | 1 |
DB11652 | Tucatinib | 1 / 2 | Recruiting | 1 |
DB12170 | Veledimex | 1 / 2 | Completed | 1 |
DB00361 | Vinorelbine | 1 / 2 | Completed | 1 |
DB00361 | Vinorelbine | 1 / 2 | Terminated | 2 |
DB00361 | Vinorelbine | 1 / 2 | Unknown Status | 1 |
DB16063 | 2X-121 | 2 | Active Not Recruiting | 1 |
DB12001 | Abemaciclib | 2 | Active Not Recruiting | 3 |
DB12001 | Abemaciclib | 2 | Completed | 1 |
DB12001 | Abemaciclib | 2 | Not Yet Recruiting | 1 |
DB12001 | Abemaciclib | 2 | Recruiting | 3 |
DB08885 | Aflibercept | 2 | Completed | 1 |
DB00062 | Albumin human | 2 | Completed | 1 |
DB00062 | Albumin human | 2 | Recruiting | 1 |
DB12015 | Alpelisib | 2 | Completed | 1 |
DB12015 | Alpelisib | 2 | Recruiting | 2 |
DB06263 | Amrubicin | 2 | Withdrawn | 1 |
DB01217 | Anastrozole | 2 | Active Not Recruiting | 3 |
DB01217 | Anastrozole | 2 | Completed | 4 |
DB01217 | Anastrozole | 2 | Not Yet Recruiting | 2 |
DB01217 | Anastrozole | 2 | Recruiting | 1 |
DB01217 | Anastrozole | 2 | Terminated | 2 |
DB01217 | Anastrozole | 2 | Unknown Status | 2 |
DB11885 | Anlotinib | 2 | Recruiting | 1 |
DB11595 | Atezolizumab | 2 | Completed | 1 |
DB11595 | Atezolizumab | 2 | Recruiting | 2 |
DB11945 | Avelumab | 2 | Active Not Recruiting | 2 |
DB05051 | BZL101 | 2 | Unknown Status | 1 |
DB00112 | Bevacizumab | 2 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Completed | 14 |
DB00112 | Bevacizumab | 2 | Recruiting | 2 |
DB00112 | Bevacizumab | 2 | Terminated | 3 |
DB00112 | Bevacizumab | 2 | Unknown Status | 2 |
DB01128 | Bicalutamide | 2 | Active Not Recruiting | 1 |
DB00188 | Bortezomib | 2 | Terminated | 1 |
DB16741 | Bortezomib D-mannitol | 2 | Terminated | 1 |
DB11666 | Buparlisib | 2 | Completed | 1 |
DB08907 | Canagliflozin | 2 | Recruiting | 1 |
DB01101 | Capecitabine | 2 | Active Not Recruiting | 4 |
DB01101 | Capecitabine | 2 | Completed | 16 |
DB01101 | Capecitabine | 2 | Not Yet Recruiting | 1 |
DB01101 | Capecitabine | 2 | Recruiting | 6 |
DB01101 | Capecitabine | 2 | Terminated | 5 |
DB01101 | Capecitabine | 2 | Unknown Status | 4 |
DB01101 | Capecitabine | 2 | Withdrawn | 1 |
DB12218 | Capivasertib | 2 | Active Not Recruiting | 2 |
DB00958 | Carboplatin | 2 | Active Not Recruiting | 2 |
DB00958 | Carboplatin | 2 | Completed | 8 |
DB00958 | Carboplatin | 2 | Not Yet Recruiting | 2 |
DB00958 | Carboplatin | 2 | Recruiting | 1 |
DB00958 | Carboplatin | 2 | Terminated | 2 |
DB00958 | Carboplatin | 2 | Withdrawn | 1 |
DB00482 | Celecoxib | 2 | Terminated | 1 |
DB00002 | Cetuximab | 2 | Active Not Recruiting | 1 |
DB00002 | Cetuximab | 2 | Completed | 1 |
DB00169 | Cholecalciferol | 2 | Completed | 1 |
DB00515 | Cisplatin | 2 | Active Not Recruiting | 1 |
DB00515 | Cisplatin | 2 | Completed | 6 |
DB00515 | Cisplatin | 2 | Recruiting | 3 |
DB00515 | Cisplatin | 2 | Terminated | 2 |
DB00515 | Cisplatin | 2 | Unknown Status | 2 |
DB00515 | Cisplatin | 2 | Withdrawn | 1 |
DB05759 | Cixutumumab | 2 | Completed | 1 |
DB12250 | Cixutumumab | 2 | Completed | 1 |
DB09130 | Copper | 2 | Recruiting | 2 |
DB11672 | Curcumin | 2 | Completed | 1 |
DB00531 | Cyclophosphamide | 2 | Active Not Recruiting | 2 |
DB00531 | Cyclophosphamide | 2 | Completed | 4 |
DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Terminated | 3 |
DB11651 | Dactolisib | 2 | Withdrawn | 1 |
DB06292 | Dapagliflozin | 2 | Recruiting | 1 |
DB01254 | Dasatinib | 2 | Completed | 1 |
DB01234 | Dexamethasone | 2 | Completed | 2 |
DB08809 | Dichloroacetic acid | 2 | Terminated | 1 |
DB00390 | Digoxin | 2 | Terminated | 1 |
DB00822 | Disulfiram | 2 | Recruiting | 2 |
DB01248 | Docetaxel | 2 | Active Not Recruiting | 1 |
DB01248 | Docetaxel | 2 | Completed | 15 |
DB01248 | Docetaxel | 2 | Not Yet Recruiting | 1 |
DB01248 | Docetaxel | 2 | Terminated | 1 |
DB01248 | Docetaxel | 2 | Unknown Status | 2 |
DB05928 | Dovitinib | 2 | Completed | 1 |
DB05928 | Dovitinib | 2 | Terminated | 1 |
DB00997 | Doxorubicin | 2 | Active Not Recruiting | 2 |
DB00997 | Doxorubicin | 2 | Completed | 5 |
DB00997 | Doxorubicin | 2 | Recruiting | 1 |
DB00997 | Doxorubicin | 2 | Terminated | 2 |
DB00997 | Doxorubicin | 2 | Unknown Status | 3 |
DB11714 | Durvalumab | 2 | Active Not Recruiting | 1 |
DB11714 | Durvalumab | 2 | Completed | 1 |
DB03516 | Eniluracil | 2 | Unknown Status | 1 |
DB12078 | Enobosarm | 2 | Completed | 1 |
DB00445 | Epirubicin | 2 | Active Not Recruiting | 1 |
DB08871 | Eribulin | 2 | Active Not Recruiting | 1 |
DB08871 | Eribulin | 2 | Completed | 4 |
DB08871 | Eribulin | 2 | Recruiting | 2 |
DB08871 | Eribulin | 2 | Terminated | 3 |
DB08871 | Eribulin | 2 | Unknown Status | 1 |
DB08871 | Eribulin | 2 | Withdrawn | 1 |
DB00530 | Erlotinib | 2 | Terminated | 2 |
DB00783 | Estradiol | 2 | Active Not Recruiting | 1 |
DB00783 | Estradiol | 2 | Not Yet Recruiting | 1 |
DB14951 | Etirinotecan pegol | 2 | Completed | 1 |
DB00773 | Etoposide | 2 | Completed | 1 |
DB01590 | Everolimus | 2 | Completed | 4 |
DB01590 | Everolimus | 2 | Not Yet Recruiting | 1 |
DB01590 | Everolimus | 2 | Unknown Status | 2 |
DB00990 | Exemestane | 2 | Active Not Recruiting | 5 |
DB00990 | Exemestane | 2 | Completed | 4 |
DB00990 | Exemestane | 2 | Not Yet Recruiting | 4 |
DB00990 | Exemestane | 2 | Recruiting | 1 |
DB00990 | Exemestane | 2 | Withdrawn | 1 |
DB11741 | Famitinib | 2 | Recruiting | 1 |
DB00099 | Filgrastim | 2 | Completed | 2 |
DB14953 | Firtecan pegol | 2 | Terminated | 1 |
DB00544 | Fluorouracil | 2 | Unknown Status | 1 |
DB01185 | Fluoxymesterone | 2 | Terminated | 1 |
DB12396 | Fresolimumab | 2 | Completed | 1 |
DB00947 | Fulvestrant | 2 | Active Not Recruiting | 7 |
DB00947 | Fulvestrant | 2 | Completed | 11 |
DB00947 | Fulvestrant | 2 | Not Yet Recruiting | 3 |
DB00947 | Fulvestrant | 2 | Recruiting | 8 |
DB00947 | Fulvestrant | 2 | Terminated | 4 |
DB00947 | Fulvestrant | 2 | Unknown Status | 2 |
DB15149 | Futibatinib | 2 | Recruiting | 1 |
DB11896 | Gedatolisib | 2 | Recruiting | 1 |
DB00317 | Gefitinib | 2 | Completed | 1 |
DB00441 | Gemcitabine | 2 | Active Not Recruiting | 1 |
DB00441 | Gemcitabine | 2 | Completed | 15 |
DB00441 | Gemcitabine | 2 | Not Yet Recruiting | 1 |
DB00441 | Gemcitabine | 2 | Recruiting | 1 |
DB00441 | Gemcitabine | 2 | Unknown Status | 1 |
DB00644 | Gonadorelin | 2 | Active Not Recruiting | 1 |
DB00014 | Goserelin | 2 | Completed | 2 |
DB00014 | Goserelin | 2 | Recruiting | 1 |
DB00014 | Goserelin | 2 | Unknown Status | 3 |
DB00014 | Goserelin | 2 | Withdrawn | 1 |
DB00117 | Histidine | 2 | Terminated | 1 |
DB11737 | Icotinib | 2 | Terminated | 1 |
DB06370 | Indisulam | 2 | Terminated | 1 |
DB12827 | Indoximod | 2 | Completed | 1 |
DB05975 | Iniparib | 2 | Completed | 1 |
DB11743 | Ipatasertib | 2 | Not Yet Recruiting | 1 |
DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
DB00762 | Irinotecan | 2 | Active Not Recruiting | 1 |
DB00762 | Irinotecan | 2 | Completed | 2 |
DB00762 | Irinotecan | 2 | Recruiting | 1 |
DB12437 | Irosustat | 2 | Completed | 1 |
DB04845 | Ixabepilone | 2 | Completed | 9 |
DB04845 | Ixabepilone | 2 | Recruiting | 1 |
DB04845 | Ixabepilone | 2 | Terminated | 1 |
DB04845 | Ixabepilone | 2 | Withdrawn | 1 |
DB01026 | Ketoconazole | 2 | Completed | 1 |
DB01259 | Lapatinib | 2 | Completed | 5 |
DB01259 | Lapatinib | 2 | Terminated | 7 |
DB01259 | Lapatinib | 2 | Unknown Status | 4 |
DB01259 | Lapatinib | 2 | Withdrawn | 1 |
DB12984 | Larotaxel | 2 | Completed | 1 |
DB06202 | Lasofoxifene | 2 | Active Not Recruiting | 1 |
DB01006 | Letrozole | 2 | Active Not Recruiting | 4 |
DB01006 | Letrozole | 2 | Completed | 10 |
DB01006 | Letrozole | 2 | Not Yet Recruiting | 3 |
DB01006 | Letrozole | 2 | Recruiting | 4 |
DB01006 | Letrozole | 2 | Unknown Status | 1 |
DB00650 | Leucovorin | 2 | Completed | 1 |
DB00650 | Leucovorin | 2 | Unknown Status | 1 |
DB00007 | Leuprolide | 2 | Active Not Recruiting | 1 |
DB00007 | Leuprolide | 2 | Completed | 2 |
DB06080 | Linifanib | 2 | Completed | 1 |
DB00279 | Liothyronine | 2 | Terminated | 1 |
DB11861 | Litronesib | 2 | Completed | 1 |
DB06448 | Lonafarnib | 2 | Terminated | 1 |
DB16221 | Lonaprisan | 2 | Completed | 1 |
DB00836 | Loperamide | 2 | Active Not Recruiting | 1 |
DB11845 | Lucitanib | 2 | Terminated | 1 |
DB16828 | MK-2206 | 2 | Withdrawn | 1 |
DB14967 | Margetuximab | 2 | Recruiting | 1 |
DB14967 | Margetuximab | 2 | Withdrawn | 1 |
DB00331 | Metformin | 2 | Completed | 2 |
DB00331 | Metformin | 2 | Terminated | 1 |
DB00563 | Methotrexate | 2 | Active Not Recruiting | 1 |
DB00563 | Methotrexate | 2 | Recruiting | 1 |
DB00563 | Methotrexate | 2 | Terminated | 1 |
DB00305 | Mitomycin | 2 | Active Not Recruiting | 1 |
DB11828 | Neratinib | 2 | Not Yet Recruiting | 1 |
DB14933 | Nicotinamide riboside | 2 | Recruiting | 1 |
DB11793 | Niraparib | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB09074 | Olaparib | 2 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 2 | Recruiting | 2 |
DB00904 | Ondansetron | 2 | Completed | 1 |
DB11669 | Ortataxel | 2 | Completed | 1 |
DB12066 | Orteronel | 2 | Completed | 1 |
DB00526 | Oxaliplatin | 2 | Completed | 4 |
DB00526 | Oxaliplatin | 2 | Terminated | 1 |
DB00526 | Oxaliplatin | 2 | Unknown Status | 2 |
DB01229 | Paclitaxel | 2 | Active Not Recruiting | 4 |
DB01229 | Paclitaxel | 2 | Completed | 26 |
DB01229 | Paclitaxel | 2 | Recruiting | 6 |
DB01229 | Paclitaxel | 2 | Terminated | 5 |
DB13809 | Paclitaxel poliglumex | 2 | Completed | 1 |
DB09073 | Palbociclib | 2 | Active Not Recruiting | 6 |
DB09073 | Palbociclib | 2 | Completed | 3 |
DB09073 | Palbociclib | 2 | Not Yet Recruiting | 1 |
DB09073 | Palbociclib | 2 | Recruiting | 4 |
DB00282 | Pamidronic acid | 2 | Terminated | 1 |
DB01269 | Panitumumab | 2 | Completed | 1 |
DB00019 | Pegfilgrastim | 2 | Completed | 2 |
DB09037 | Pembrolizumab | 2 | Completed | 1 |
DB09037 | Pembrolizumab | 2 | Not Yet Recruiting | 2 |
DB09037 | Pembrolizumab | 2 | Recruiting | 4 |
DB09037 | Pembrolizumab | 2 | Terminated | 1 |
DB09037 | Pembrolizumab | 2 | Withdrawn | 1 |
DB00642 | Pemetrexed | 2 | Terminated | 1 |
DB00642 | Pemetrexed | 2 | Unknown Status | 1 |
DB06366 | Pertuzumab | 2 | Completed | 3 |
DB06366 | Pertuzumab | 2 | Not Yet Recruiting | 1 |
DB06366 | Pertuzumab | 2 | Terminated | 2 |
DB14805 | Piflufolastat F 18 | 2 | Recruiting | 1 |
DB12257 | Platinum | 2 | Active Not Recruiting | 1 |
DB12257 | Platinum | 2 | Completed | 3 |
DB12114 | Poziotinib | 2 | Completed | 2 |
DB01708 | Prasterone | 2 | Terminated | 1 |
DB14993 | Pyrotinib | 2 | Active Not Recruiting | 1 |
DB14993 | Pyrotinib | 2 | Not Yet Recruiting | 6 |
DB14993 | Pyrotinib | 2 | Recruiting | 4 |
DB11787 | Ralimetinib | 2 | Terminated | 1 |
DB12614 | Reparixin | 2 | Completed | 1 |
DB05626 | Retaspimycin | 2 | Terminated | 1 |
DB11730 | Ribociclib | 2 | Active Not Recruiting | 2 |
DB11730 | Ribociclib | 2 | Not Yet Recruiting | 1 |
DB14765 | Rivoceranib | 2 | Completed | 1 |
DB14765 | Rivoceranib | 2 | Unknown Status | 1 |
DB12332 | Rucaparib | 2 | Completed | 1 |
DB12893 | Sacituzumab govitecan | 2 | Recruiting | 2 |
DB05654 | Sagopilone | 2 | Completed | 1 |
DB12391 | Sagopilone | 2 | Completed | 1 |
DB12183 | Sapitinib | 2 | Active Not Recruiting | 1 |
DB04996 | Satraplatin | 2 | Completed | 1 |
DB11689 | Selumetinib | 2 | Active Not Recruiting | 1 |
DB11857 | Seribantumab | 2 | Terminated | 1 |
DB15036 | Sitravatinib | 2 | Recruiting | 2 |
DB09153 | Sodium chloride | 2 | Terminated | 1 |
DB00398 | Sorafenib | 2 | Completed | 1 |
DB00398 | Sorafenib | 2 | Terminated | 2 |
DB01268 | Sunitinib | 2 | Completed | 2 |
DB01268 | Sunitinib | 2 | Terminated | 1 |
DB00675 | Tamoxifen | 2 | Active Not Recruiting | 3 |
DB00675 | Tamoxifen | 2 | Completed | 4 |
DB00675 | Tamoxifen | 2 | Not Yet Recruiting | 1 |
DB00675 | Tamoxifen | 2 | Terminated | 1 |
DB00853 | Temozolomide | 2 | Active Not Recruiting | 1 |
DB00853 | Temozolomide | 2 | Completed | 1 |
DB15295 | Tenalisib | 2 | Active Not Recruiting | 1 |
DB12019 | Tesetaxel | 2 | Unknown Status | 1 |
DB04905 | Tesmilifene | 2 | Completed | 1 |
DB01041 | Thalidomide | 2 | Unknown Status | 1 |
DB15101 | Tigatuzumab | 2 | Completed | 1 |
DB14922 | Tislelizumab | 2 | Recruiting | 1 |
DB15043 | Toripalimab | 2 | Recruiting | 1 |
DB00072 | Trastuzumab | 2 | Active Not Recruiting | 4 |
DB00072 | Trastuzumab | 2 | Completed | 14 |
DB00072 | Trastuzumab | 2 | Not Yet Recruiting | 3 |
DB00072 | Trastuzumab | 2 | Recruiting | 3 |
DB00072 | Trastuzumab | 2 | Terminated | 5 |
DB00072 | Trastuzumab | 2 | Unknown Status | 4 |
DB00072 | Trastuzumab | 2 | Withdrawn | 1 |
DB14962 | Trastuzumab deruxtecan | 2 | Recruiting | 1 |
DB05773 | Trastuzumab emtansine | 2 | Active Not Recruiting | 1 |
DB05773 | Trastuzumab emtansine | 2 | Completed | 5 |
DB05773 | Trastuzumab emtansine | 2 | Recruiting | 1 |
DB11771 | Tremelimumab | 2 | Completed | 1 |
DB11652 | Tucatinib | 2 | Active Not Recruiting | 1 |
DB11652 | Tucatinib | 2 | Withdrawn | 1 |
DB05558 | Upamostat | 2 | Completed | 1 |
DB05294 | Vandetanib | 2 | Active Not Recruiting | 1 |
DB05294 | Vandetanib | 2 | Completed | 1 |
DB12723 | Varlitinib | 2 | Completed | 1 |
DB07232 | Veliparib | 2 | Active Not Recruiting | 1 |
DB07232 | Veliparib | 2 | Completed | 1 |
DB00460 | Verteporfin | 2 | Unknown Status | 1 |
DB00570 | Vinblastine | 2 | Active Not Recruiting | 1 |
DB00541 | Vincristine | 2 | Active Not Recruiting | 1 |
DB00361 | Vinorelbine | 2 | Active Not Recruiting | 3 |
DB00361 | Vinorelbine | 2 | Completed | 6 |
DB00361 | Vinorelbine | 2 | Not Yet Recruiting | 3 |
DB00361 | Vinorelbine | 2 | Recruiting | 4 |
DB00361 | Vinorelbine | 2 | Terminated | 2 |
DB00361 | Vinorelbine | 2 | Unknown Status | 3 |
DB11925 | Vistusertib | 2 | Active Not Recruiting | 1 |
DB11094 | Vitamin D | 2 | Completed | 1 |
DB15559 | Zenocutuzumab | 2 | Active Not Recruiting | 1 |
DB06629 | Zibotentan | 2 | Withdrawn | 1 |
DB00399 | Zoledronic acid | 2 | Terminated | 1 |
DB05136 | Bavituximab | 2 / 3 | Withdrawn | 1 |
DB01101 | Capecitabine | 2 / 3 | Completed | 1 |
DB00958 | Carboplatin | 2 / 3 | Completed | 1 |
DB01248 | Docetaxel | 2 / 3 | Withdrawn | 1 |
DB00099 | Filgrastim | 2 / 3 | Terminated | 1 |
DB00441 | Gemcitabine | 2 / 3 | Completed | 1 |
DB01006 | Letrozole | 2 / 3 | Completed | 1 |
DB01229 | Paclitaxel | 2 / 3 | Completed | 1 |
DB01229 | Paclitaxel | 2 / 3 | Withdrawn | 1 |
DB00072 | Trastuzumab | 2 / 3 | Terminated | 1 |
DB00361 | Vinorelbine | 2 / 3 | Terminated | 1 |
DB00399 | Zoledronic acid | 2 / 3 | Completed | 1 |
DB12001 | Abemaciclib | 3 | Recruiting | 1 |
DB05812 | Abiraterone | 3 | Completed | 1 |
DB01217 | Anastrozole | 3 | Active Not Recruiting | 1 |
DB01217 | Anastrozole | 3 | Completed | 1 |
DB01217 | Anastrozole | 3 | Recruiting | 1 |
DB11595 | Atezolizumab | 3 | Recruiting | 1 |
DB15370 | Balixafortide | 3 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 3 | Completed | 5 |
DB00112 | Bevacizumab | 3 | Unknown Status | 1 |
DB11666 | Buparlisib | 3 | Terminated | 1 |
DB01101 | Capecitabine | 3 | Active Not Recruiting | 2 |
DB01101 | Capecitabine | 3 | Completed | 6 |
DB01101 | Capecitabine | 3 | Recruiting | 3 |
DB01101 | Capecitabine | 3 | Terminated | 2 |
DB01101 | Capecitabine | 3 | Unknown Status | 2 |
DB00958 | Carboplatin | 3 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 3 | Unknown Status | 1 |
DB00482 | Celecoxib | 3 | Completed | 1 |
DB06643 | Denosumab | 3 | Recruiting | 1 |
DB01248 | Docetaxel | 3 | Completed | 3 |
DB01248 | Docetaxel | 3 | Recruiting | 2 |
DB01248 | Docetaxel | 3 | Terminated | 1 |
DB00997 | Doxorubicin | 3 | Completed | 1 |
DB00997 | Doxorubicin | 3 | Terminated | 1 |
DB12078 | Enobosarm | 3 | Recruiting | 2 |
DB00445 | Epirubicin | 3 | Completed | 1 |
DB08871 | Eribulin | 3 | Active Not Recruiting | 3 |
DB08871 | Eribulin | 3 | Completed | 1 |
DB08871 | Eribulin | 3 | Recruiting | 2 |
DB14951 | Etirinotecan pegol | 3 | Completed | 1 |
DB01590 | Everolimus | 3 | Completed | 3 |
DB01590 | Everolimus | 3 | Recruiting | 1 |
DB01590 | Everolimus | 3 | Terminated | 1 |
DB01590 | Everolimus | 3 | Unknown Status | 1 |
DB00990 | Exemestane | 3 | Active Not Recruiting | 1 |
DB00990 | Exemestane | 3 | Completed | 6 |
DB00990 | Exemestane | 3 | Recruiting | 3 |
DB00990 | Exemestane | 3 | Unknown Status | 1 |
DB00947 | Fulvestrant | 3 | Active Not Recruiting | 2 |
DB00947 | Fulvestrant | 3 | Completed | 2 |
DB00947 | Fulvestrant | 3 | Recruiting | 4 |
DB00947 | Fulvestrant | 3 | Terminated | 1 |
DB00947 | Fulvestrant | 3 | Unknown Status | 3 |
DB00441 | Gemcitabine | 3 | Active Not Recruiting | 1 |
DB00441 | Gemcitabine | 3 | Completed | 1 |
DB00441 | Gemcitabine | 3 | Recruiting | 1 |
DB00441 | Gemcitabine | 3 | Unknown Status | 1 |
DB09257 | Gimeracil | 3 | Terminated | 1 |
DB00014 | Goserelin | 3 | Recruiting | 1 |
DB14070 | HM-30181 | 3 | Completed | 1 |
DB00762 | Irinotecan | 3 | Unknown Status | 1 |
DB01259 | Lapatinib | 3 | Active Not Recruiting | 2 |
DB01259 | Lapatinib | 3 | Unknown Status | 1 |
DB01006 | Letrozole | 3 | Active Not Recruiting | 1 |
DB01006 | Letrozole | 3 | Completed | 1 |
DB01006 | Letrozole | 3 | Recruiting | 2 |
DB00007 | Leuprolide | 3 | Recruiting | 1 |
DB00351 | Megestrol acetate | 3 | Completed | 1 |
DB09074 | Olaparib | 3 | Active Not Recruiting | 1 |
DB03209 | Oteracil | 3 | Terminated | 1 |
DB01229 | Paclitaxel | 3 | Active Not Recruiting | 2 |
DB01229 | Paclitaxel | 3 | Completed | 7 |
DB01229 | Paclitaxel | 3 | Recruiting | 2 |
DB01229 | Paclitaxel | 3 | Unknown Status | 1 |
DB09073 | Palbociclib | 3 | Active Not Recruiting | 2 |
DB09073 | Palbociclib | 3 | Completed | 1 |
DB09073 | Palbociclib | 3 | Recruiting | 1 |
DB06366 | Pertuzumab | 3 | Completed | 1 |
DB06366 | Pertuzumab | 3 | Not Yet Recruiting | 1 |
DB06366 | Pertuzumab | 3 | Recruiting | 1 |
DB00635 | Prednisone | 3 | Completed | 1 |
DB14993 | Pyrotinib | 3 | Recruiting | 2 |
DB11730 | Ribociclib | 3 | Recruiting | 2 |
DB12893 | Sacituzumab govitecan | 3 | Active Not Recruiting | 1 |
DB12893 | Sacituzumab govitecan | 3 | Recruiting | 1 |
DB09256 | Tegafur | 3 | Terminated | 1 |
DB00072 | Trastuzumab | 3 | Active Not Recruiting | 2 |
DB00072 | Trastuzumab | 3 | Completed | 4 |
DB00072 | Trastuzumab | 3 | Recruiting | 3 |
DB00072 | Trastuzumab | 3 | Terminated | 1 |
DB00072 | Trastuzumab | 3 | Unknown Status | 1 |
DB16342 | Trastuzumab duocarmazine | 3 | Active Not Recruiting | 1 |
DB05773 | Trastuzumab emtansine | 3 | Recruiting | 1 |
DB05773 | Trastuzumab emtansine | 3 | Terminated | 1 |
DB07232 | Veliparib | 3 | Active Not Recruiting | 1 |
DB00361 | Vinorelbine | 3 | Active Not Recruiting | 2 |
DB00361 | Vinorelbine | 3 | Completed | 2 |
DB00361 | Vinorelbine | 3 | Recruiting | 2 |
DB12001 | Abemaciclib | 4 | Terminated | 1 |
DB12001 | Abemaciclib | 4 | Withdrawn | 1 |
DB01217 | Anastrozole | 4 | Recruiting | 1 |
DB01101 | Capecitabine | 4 | Recruiting | 1 |
DB01101 | Capecitabine | 4 | Terminated | 1 |
DB00958 | Carboplatin | 4 | Unknown Status | 1 |
DB01248 | Docetaxel | 4 | Terminated | 1 |
DB00445 | Epirubicin | 4 | Recruiting | 1 |
DB00445 | Epirubicin | 4 | Unknown Status | 1 |
DB08871 | Eribulin | 4 | Completed | 1 |
DB08871 | Eribulin | 4 | Recruiting | 1 |
DB00990 | Exemestane | 4 | Recruiting | 1 |
DB00947 | Fulvestrant | 4 | Completed | 1 |
DB00947 | Fulvestrant | 4 | Not Yet Recruiting | 1 |
DB00947 | Fulvestrant | 4 | Recruiting | 2 |
DB00947 | Fulvestrant | 4 | Terminated | 1 |
DB00014 | Goserelin | 4 | Not Yet Recruiting | 1 |
DB00014 | Goserelin | 4 | Recruiting | 1 |
DB01006 | Letrozole | 4 | Recruiting | 2 |
DB01006 | Letrozole | 4 | Terminated | 2 |
DB01229 | Paclitaxel | 4 | Recruiting | 2 |
DB01229 | Paclitaxel | 4 | Terminated | 1 |
DB01229 | Paclitaxel | 4 | Unknown Status | 1 |
DB09073 | Palbociclib | 4 | Recruiting | 1 |
DB11730 | Ribociclib | 4 | Recruiting | 1 |
DB00675 | Tamoxifen | 4 | Recruiting | 2 |
DB00072 | Trastuzumab | 4 | Terminated | 1 |
DB00361 | Vinorelbine | 4 | Recruiting | 2 |
DB00399 | Zoledronic acid | 4 | Unknown Status | 1 |
DB12001 | Abemaciclib | Not Available | Approved for Marketing | 1 |
DB12001 | Abemaciclib | Not Available | Available | 1 |
DB12001 | Abemaciclib | Not Available | Completed | 2 |
DB00062 | Albumin human | Not Available | Completed | 1 |
DB01217 | Anastrozole | Not Available | Completed | 1 |
DB00112 | Bevacizumab | Not Available | Not Yet Recruiting | 1 |
DB01101 | Capecitabine | Not Available | Completed | 1 |
DB01101 | Capecitabine | Not Available | Recruiting | 1 |
DB00531 | Cyclophosphamide | Not Available | Recruiting | 1 |
DB00997 | Doxorubicin | Not Available | Completed | 1 |
DB11714 | Durvalumab | Not Available | Completed | 1 |
DB08871 | Eribulin | Not Available | Approved for Marketing | 1 |
DB08871 | Eribulin | Not Available | Unknown Status | 1 |
DB01590 | Everolimus | Not Available | Active Not Recruiting | 2 |
DB00990 | Exemestane | Not Available | Active Not Recruiting | 1 |
DB15690 | Fluoroestradiol F-18 | Not Available | Not Yet Recruiting | 1 |
DB00947 | Fulvestrant | Not Available | Active Not Recruiting | 1 |
DB00947 | Fulvestrant | Not Available | Completed | 3 |
DB00441 | Gemcitabine | Not Available | Completed | 1 |
DB01006 | Letrozole | Not Available | Active Not Recruiting | 1 |
DB01006 | Letrozole | Not Available | Completed | 1 |
DB01229 | Paclitaxel | Not Available | Completed | 2 |
DB09073 | Palbociclib | Not Available | Active Not Recruiting | 2 |
DB09073 | Palbociclib | Not Available | Completed | 6 |
DB09073 | Palbociclib | Not Available | Not Yet Recruiting | 1 |
DB09073 | Palbociclib | Not Available | Recruiting | 2 |
DB06641 | Perifosine | Not Available | Completed | 1 |
DB14993 | Pyrotinib | Not Available | Not Yet Recruiting | 1 |
DB11730 | Ribociclib | Not Available | Completed | 2 |
DB01268 | Sunitinib | Not Available | Completed | 1 |
DB11760 | Talazoparib | Not Available | Completed | 1 |
DB00675 | Tamoxifen | Not Available | Completed | 1 |
DB00072 | Trastuzumab | Not Available | Completed | 1 |
DB00072 | Trastuzumab | Not Available | Not Yet Recruiting | 1 |
DB05773 | Trastuzumab emtansine | Not Available | No Longer Available | 1 |
DB11771 | Tremelimumab | Not Available | Completed | 1 |